We have a massive concentration risk with our primary software vendor, which our buyer is using to argue for a steep discount on our multiple. How do we use the principle of substitution and a risk-adjusted income approach to prove this is a manageable operating condition rather than a structural valuation impairment?

Question

Tyler Smith · Accepted Answer

To counter a valuation discount based on vendor concentration, you must shift the debate from a generic risk assessment to a quantified analysis of the principle of substitution. Buyers fear a single point of failure. You must prove that your operational reliance on this specific software vendor is a strategic choice, not a structural vulnerability.

First, map out your operational processes using your EOS® documentation. Show the buyer how your core processes are documented and institutionalized. Explain that while the software vendor provides the technical infrastructure, your team's execution of your proprietary workflows is the real driver of your high profit margins.

Second, present a transition and substitution plan. Under the principle of substitution, the value of your business should not be discounted if an alternative vendor can be integrated with minimal disruption. Calculate the exact time and cost required to migrate your data pipelines and operations to a secondary provider. Prove that your internal tech stack is built on open APIs and flexible architecture, making migration a project with a fixed, manageable cost rather than a catastrophic event.

Third, adjust your valuation models using a risk-adjusted income approach under IVS 105. Quantify the migration cost as a one-time capital expenditure adjustment rather than letting the buyer apply a permanent, subjective multiple discount across your entire trailing EBITDA. By framing this as a solvable operational transition with a defined price tag, you neutralize their leverage and defend your enterprise value.